Font Size: a A A
Keyword [fetal DNA]
Result: 21 - 40 | Page: 2 of 4
21. Quantitative Detection Of Fetal DNA In Maternal Plasma And Its Clinical Significance In The Prediction Of Parturient Period And Preterm Labor
22. Study Of Method To Enrich Fatal Dna In Maternal Plasma With Immunology Magnetic Beads
23. Study Of Non-invasive Prenatal Diagnosis Using Cell-free Fetal DNA In Maternal Plasma
24. A Feasible Study About The Application Of Fetal DNA In Cervical Mucus Of Early Pregnancy In Prenatal Diagnosis
25. Detection And Analysis Of Cell-free Fetal Dna In Maternal Plasma
26. First Trimester Screening And Diagnosis For Fetal Chromosome Aneuploidy Abnormalities
27. Development Of A Non-Invasive Prenatal Diagnostic Test For Beta-Thalassaemia Using Cell-free Fetal DNA
28. Establish A Method Of Cell-free Fetal DNA In Maternal Plasma Selective Amplification And Its Application In Trisomy21Noninvasive Prenatal Testing
29. The Genetic Analysis About NIPT-Fetal Discordant Results
30. The Research Of Cell-Free Fetal DNA In Maternal Blood In Predicting Fetal Blood Groups
31. Analysis On Size Distribution And DNA Concentrations Of Circulatory DNA In Maternal Plasma
32. Non-invasive Testing For The Determination Of The Fetal RhCcE Factor In Maternal Plasma
33. A Systematic Review Of Accuracy Of Microarray Analysis And Maternal Serum Free Fetal DNA For Prenatal Diagnosis Of Chromosomal Abnormalities
34. Noninvasive Prenatal Test By Sequencing Of Maternal Plasma Cell-free DN A In First Trimester For Advanced Maternal Age Pregnancies
35. Construction Of The Method Based On Quantitative Detection Of Sex Chromosome For Non-invasive Screening Of Sex-linked Genetic Diseases
36. Use Of Free Fetal DNA In Maternal Plasma To Noninvasive Prenatal Diagnosis β-thalassemia Methods Research
37. Massively Parallel Sequencing Method For Chromosomal Aneuploidy In Prenatal Testing And Karyotype Analysis Of Amniotic Fluid Cells
38. Combining The Effects Of Cell-free Circulating Tumor DNA With The Noninvasive Prenatal Testing Results Of Breast Tumor Patients By A Simulating Investigation
39. Screening And Identification Of Differentially Methylated Markers Between Maternal And Fetal DNA
40. Analysis Of Correlation Of Peripheral Blood Cell-free Placental MRNA?cell-free Fetal DNA?Vasculoendothelial Growth Factor And Soluble Fms-like Tyrosine Kinase Level With The Risk Of Placenta Accreta In Pregnant Women
  <<First  <Prev  Next>  Last>>  Jump to